Yes, your interpretation is correct.
The low hanging fruit here is obviously liver PFS, given that it's been prescribed for late stage with success for sometime. The results would just be icing on the cake, so to speak.
Clinical Trial Objectives, page-6
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.5¢ | $132.6K | 758.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 449688 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 955405 | 27 |
View Market Depth
| Last trade - 15.47pm 30/08/2024 (20 minute delay) ? |
| SRX (ASX) Chart |